Document is current
Any future updates will be listed below
-
Authors
Riley, Lisa G.
Sabui, Subrata
Said, Hamid M.
Niaz, Aram https://orcid.org/0000-0001-6636-2555
Girisha, Katta M. https://orcid.org/0000-0002-0139-8239
Radhakrishnan, Periyasamy
Nampoothiri, Sheela https://orcid.org/0000-0002-9575-0722
Yesodharan, Dhanya
Kilo, Tatjana
Smith, Janine
Wong, Rachel S. H.
Menezes, Manoj P.
Gupta, Sachin
Cooper, Sandra T. https://orcid.org/0000-0002-7314-5097
Balasubramaniam, Shanti
-
Funding
Funding for this research was provided by:
Luminesce Alliance- Innovation for Children’s Health. NSW Government, Australia
U.S. Department of Veterans Affairs (I01BX001142, I01BX001142, IK6BX006189)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (AA018071)
U.S. Department of Health & Human Services | National Institutes of Health (AA018071)
- License Information
-
More Information
Article History
Received: 3 January 2024
Revised: 29 April 2024
Accepted: 16 May 2024
First Online: 30 May 2024
Competing interests
: LGR, SS, HMS, AN, SN, DY, TK, JS, RSHW, MPM, SG, and SB declare that they have no conflict of interest. STC is director of Frontier Genomics Pty Ltd (Australia). STC currently receives no consultancy fees or other remuneration for this role. Frontier Genomics Pty Ltd (Australia) has no existing financial relationships that will benefit from publication of these data. KMG is the director of Suma Genomics Private Limited. PR is a scientist in Suma Genomics Private Limited. KMG and PR do not have any financial conflicts of interest. Suma Genomics Private Limited has no financial benefit by publishing these data.
: Ethical approval was obtained from the Human Research Ethics Committee of The Children’s Hospital at Westmead, Australia (2019/ETH11736). Informed written consent was obtained from all study participants or their guardians.
